ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In

October 10, 2014

LeMaistre Succeeds Lee Clark As Head Of U. Texas Center

March 10, 1978

Bush Appoints Kripke To President’s Cancer Panel

February 21, 2003

In Brief: Lasker Foundation Will Not Make 1990 Awards; Michigan Cancer Elects Fischer Vice Chairman

March 2, 1990

Two More CHOPs Funded By NCI

March 6, 1981

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011